Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

KA Vallis, RM Reilly, D Scollard, P Merante, A Brade, S Velauthapillai, C Caldwell, I Chan, M Freeman, G Lockwood, NA Miller, B Cornelissen, J Petronis, K Sabate

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)181-192
Number of pages12
JournalAmerican journal of nuclear medicine and molecular imaging
Volume20
Issue number4
Publication statusPublished - Mar-2014
Externally publishedYes

Cite this